Global Antidepressant Market size was valued at USD 16.44 Bn. in 2023 and the total Global Antidepressant revenue is expected to grow at a CAGR of 7.2% from 2024 to 2030, reaching nearly USD 26.75 Bn. in 2030.Global Antidepressant Market Overview:
Antidepressants are a type of drug that decreases symptoms of depressive disorders by acting against chemical imbalances of neurotransmitters in the brain. Antidepressant drugs are used for the treatment of depressive disorders, anxiety disorders, and chronic pain conditions and to manage some addictions. Antidepressants have some side effects such as dry mouth, weight gain, dizziness, headaches, sexual dysfunction and sometimes increased thoughts of suicide when taken by children, young adults and adolescents. After stopping antidepressants a discontinuation syndrome can occur and this resembles recurrent depression. According to the MMR analysis, mental health expenditure is a crucial aspect of the healthcare system, as it determines the availability, accessibility, and quality of mental health services. The WHO recommends that countries allocate at least 5% of their healthcare budget to mental health, but many countries fall short of the target. Global mental health expenditure varies widely across countries and regions. In low-income countries, mental health expenditure is often very low, with many countries spending less than 1% of their healthcare budget on mental health. In contrast, high-income countries tend to spend more on mental health, with some countries spending over 10% of their healthcare budget on mental health. Antidepressants remained in the BNF section with the largest number of identified patients and items prescribed. In 2023, 86 million antidepressants were prescribed to an estimated 8.6 million identified patients. Common Antidepressants Medications. 1. Selective serotonin reuptake inhibitors (SSRIs) 2. Serotonin and norepinephrine reuptake inhibitors (SNRIs) 3. Tricyclic antidepressants (TCAs) 4. Monoamine oxidase inhibitors (MAOIs)To know about the Research Methodology :- Request Free Sample Report
Global Antidepressant Market Dynamics:
Rising Demand and Expansion of the Antidepressant Market The Antidepressant Market is expected to grow in the forecast owing to driving factors such as the increasing geriatric population, increasing prevalence of depression, and development of new drugs with minor side effects are driving the growth of the market. As the prevalence of depression continues to increase, the demand for antidepressant drugs is expected to grow. In addition, the growing awareness about mental health issues and the availability of effective treatments are also driving market growth. The increasing number of clinical trials leading to increasing novel drug approvals for treating ant depression fuel the market growth. Market leaders and government organizations are proactively involved in expanding product availability across the middle as well as low-income groups.Innovations Driving Antidepressant Market Growth from New Drugs to AI Solutions The development of new antidepressant drugs and the advancement of drug delivery technologies have contributed to market growth. Innovative formulations, such as extended-release formulations and novel drug delivery systems, enhance patient compliance and improve treatment outcomes. Technological advancements drive the demand for newer antidepressant drugs and support market expansion. Several start-ups, healthcare technology entities, and academic institutions have been AI-based algorithms, systems, and tools for depression. For example, Baltimore-based Sunrise Health, a start-up incubated under Johns Hopkins Technology Ventures, has developed a system that uses AI-based predictive analytics to regulate patient activity and inhibit the onset of mental health breakdown episodes through support-group texting. On the other hand, California-based start-up, Mind Strong Health, utilizes machine learning (ML) to aid the diagnosis and treatment of behavioural health disorders by leveraging data generated from smartphones. AI has displayed vast potential in enhancing the efficacy and accuracy of antidepressants, thereby brightening the outlook of the market. Navigating Challenges, Side Effects and Regulatory Hurdles in the Antidepressant Market The side effects of antidepressant drugs are a key factor hampering the growth of the antidepressant market. The antidepressants (escitalopram) and Celexa (citalopram), both are used to treat depression and Lexapro also helps treat anxiety. Lexapro and Celexa cause side effects common to others such as nausea, sleeplessness, sweating, dry mouth, and drowsiness. Celexa and Lexapro are both at risk for even more serious side effects including excessive bleeding, seizures, and vision issues. Antidepressant drugs are used in disorders such as agitation, obsessive-compulsive disorders (OCD), childhood enuresis, major depressive disorder, generalized anxiety disorder, bipolar disorder, posttraumatic stress disorder (PTSD), social anxiety disorder etc. Antidepressant drugs are also used in off-label cases such as insomnia, pain and migraine. Almost 29% of antidepressant drugs are used for off-label purposes. Side effects during the medication of drugs are the main restraining factor for the antidepressant drugs market. The stringent regulatory requirements for the approval of antidepressant drugs also pose a challenge to market growth. The complex and time-consuming clinical trials, high development costs, and increasing regulatory scrutiny delay the approval and launch of new antidepressant drugs.
Global Antidepressant Market Segmentation:
Based on Depression Disorder, Depression is a common mental disorder. It involves a depressed mood or loss of pleasure or interest in activities for long periods. Globally, an estimated 5% of adults suffer from depression. An estimated 3.8% of the population experience depression, including 5% of adults (4% among men and 6% among women), and 5.7% of adults older than 60 years. Approximately 280 million people in the world have depression. Depression is about 50% more common among women than among men. Worldwide, more than 10% of pregnant women and women who have just given birth experience depression More than 700 000 people die due to suicide every year. Suicide is the fourth leading cause of death in 15–29-year-olds. Adults fielded from July 26 to August 7, 2023, found that around 22 per cent of respondents reported symptoms of depressive disorder Although there are known, effective treatments for mental disorders, more than 75% of people in low- and middle-income countries receive no treatment. Barriers to effective care include a lack of investment in mental health care, lack of trained health-care providers and social stigma associated with mental disorders. 11.5% of youth (or over 2.7 million youth) are experiencing severe major depression. Rates of severe major depressive episodes were highest among youth who identified as more than one race, at 16.5% (about 123,000 youth).North America dominates the global antidepressants market with a market share of 37 %, owing to the high demand for disease-specific treatment, rise in adoption of newer technologies, presence of refined healthcare expenditure, increased patient awareness level, and high prevalence of depression. Over 40 million adults (19.1% of the population) have an anxiety disorder in the U.S. According to the U.S. Census Bureau Household Pulse Survey, nearly one-third of adults (32.3%) reported anxiety and depression symptoms in 2023. 1. According to Mental Health America (MHA), 21% of Americans had a mental disorder in 2023. Comparable to more than 50 million Americans. 2. Auvelity is an extended-release tablet that combines bupropion and dextromethorphan and was approved by the Food and Drug Administration (FDA) in August to treat major depressive disorder in adults. A competitive market for the drugs has resulted from the strong demand for depressive treatments in Canada. Antidepressant medications come in a variety of forms, such as atypical antidepressants, selective serotonin reuptake inhibitors (SSRIs), and serotonin and norepinephrine reuptake inhibitors (SNRIs). The competition promotes innovation and advancement in the antidepressant medicine industry. The market's pricing is also impacted by the increasing demand for antidepressant medications. As many antidepressants are accessible in generic form, patients find them to be more economical. In Canada, most prescription drugs, including antidepressants, are covered under Public Health Insurance Plans. Coverage for prescription drugs varies by province and territory, but most plans cover at least some portion of the cost of antidepressants. In some provinces, like Ontario and Quebec, there are also programs in place to help low-income individuals and families access prescription drugs at little or no cost.
Global Antidepressant Market Regional Insight:
New Drug Inventions 1. Zuranolone (Zurzuvae) In August 2023, The FDA approved the drug to treat postpartum depression (PPD). It’s the first drug approved to treat PPD. Zuranolone (Zurzuvae) is an oral antidepressant in the class of gamma-aminobutyric acid (GABA) receptor-positive modulators. 2. July 2023, Auvelity (bupropion and dextromethorphan) from Axsome Therapeutics received FDA approval for major depression disorder. 3. August 20233, Brintellix (Vortioxetine) from Takeda received FDA approval for postpartum depression. Merger & Acquisition 1. In February 2023, Viatris acquired the antidepressant brand Effexor from Pfizer for $5.4 billion. 2. December 2023 AbbVie completed its acquisition of Allergan’s psychiatry portfolio, including the antidepressant brands Lexapro and Trintellix.
Global Antidepressant Market Competitive Landscape:
Global Antidepressant Market Scope: Inquire before buying
Global Antidepressant Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 16.44 Bn. Forecast Period 2024 to 2030 CAGR: 7.2% Market Size in 2030: US $ 26.75 Bn. Segments Covered: By Product Tricyclic Antidepressants Selective Serotonin Reuptake Inhibitors Herbicides Serotonin-Norepinephrine Reuptake Inhibitors Monoamine Oxidase Inhibitors Serotonin Antagonist Reuptake Inhibitors By Depression Disorder Major Depressive Disorder Anxiety Disorders Attention Deficit Hyperactivity Disorder By End Users Hospitals & Clinics Homecare Speciality Centres Global Antidepressant Market, by Region:-
North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, and the Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria, and the Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key players of the Global Antidepressant Market:
1. AstraZeneca plc 2. Eli Lilly and Company 3. Forest Laboratories 4. GlaxoSmithKline plc 5. H. Lundbeck A/S 6. Johnson & Johnson 7. Merck & Co., Inc. 8. Pfizer, Inc. 9. Sanofi S.A. 10. Allergan PLC 11. Sun Pharmaceuticals Pvt Ltd. 12. Alkermes Plc 13. Bristol Myers Squibb Co 14. Teva Pharmaceutical Industries Ltd. 15. Takeda Pharmaceutical Co. Ltd. 16. Novartis AG 17. Opko Health 18. Bristol Myers Squibb Co 19. Teva Pharmaceutical Industries Ltd. 20. Takeda Pharmaceutical Co. Ltd. 21. Novartis AG 22. Opko HealthFrequently Asked Questions:
1] What segments are covered in the Global Antidepressant Market report? Ans. The segments covered in the Global Antidepressant Market report are based on product, depression disorder, and End Users. 2] Which region is expected to hold the highest share in the Global Antidepressant Market? Ans. The North America region is expected to hold the highest share of the Global Antidepressant Market. 3] What is the market size of the Global Antidepressant Market by 2030? Ans. The market size of the Global Antidepressant Market by 2030 will be $ 26.75 Billion. 4] What is the forecast period for the Global Antidepressant Market? Ans. The Forecast period for the Global Antidepressant Market is 2024- 2030.
1. Global Antidepressant Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Antidepressant Market: Dynamics 2.1. Global Antidepressant Market Trends by Region 2.1.1. North America Global Antidepressant Market Trends 2.1.2. Europe Global Antidepressant Market Trends 2.1.3. Asia Pacific Global Antidepressant Market Trends 2.1.4. Middle East and Africa Global Antidepressant Market Trends 2.1.5. South America Global Antidepressant Market Trends 2.2. Global Antidepressant Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Global Antidepressant Market Drivers 2.2.1.2. North America Global Antidepressant Market Restraints 2.2.1.3. North America Global Antidepressant Market Opportunities 2.2.1.4. North America Global Antidepressant Market Challenges 2.2.2. Europe 2.2.2.1. Europe Global Antidepressant Market Drivers 2.2.2.2. Europe Global Antidepressant Market Restraints 2.2.2.3. Europe Global Antidepressant Market Opportunities 2.2.2.4. Europe Global Antidepressant Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Global Antidepressant Market Drivers 2.2.3.2. Asia Pacific Global Antidepressant Market Restraints 2.2.3.3. Asia Pacific Global Antidepressant Market Opportunities 2.2.3.4. Asia Pacific Global Antidepressant Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Global Antidepressant Market Drivers 2.2.4.2. Middle East and Africa Global Antidepressant Market Restraints 2.2.4.3. Middle East and Africa Global Antidepressant Market Opportunities 2.2.4.4. Middle East and Africa Global Antidepressant Market Challenges 2.2.5. South America 2.2.5.1. South America Global Antidepressant Market Drivers 2.2.5.2. South America Global Antidepressant Market Restraints 2.2.5.3. South America Global Antidepressant Market Opportunities 2.2.5.4. South America Global Antidepressant Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Regulatory Landscape by Region 2.5.1. North America 2.5.2. Europe 2.5.3. Asia Pacific 2.5.4. Middle East and Africa 2.5.5. South America 2.6. Global Antidepressant Clinical Trial Analysis for Global Antidepressant 2.7. Key Opinion Leader Analysis For the Global Antidepressant Industry 2.8. Analysis of Government Schemes and Initiatives For the Global Antidepressant Industry 3. Global Antidepressant Market: Global Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2030) 3.1. Global Antidepressant Market Size and Forecast, by Product (2024-2030) 3.1.1. Tricyclic Antidepressants 3.1.2. Selective Serotonin Reuptake Inhibitors Herbicides 3.1.3. Serotonin-Norepinephrine Reuptake Inhibitors 3.1.4. Monoamine Oxidase Inhibitors 3.1.5. Serotonin Antagonist 3.1.6. Reuptake Inhibitors 3.2. Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 3.2.1. Major Depressive Disorder 3.2.2. Anxiety Disorders 3.2.3. Attention Deficit Hyperactivity Disorder 3.3. Global Antidepressant Market Size and Forecast, by End- User (2024-2030) 3.3.1. Hospitals & Clinics 3.3.2. Speciality Centres 3.3.3. Homecare 3.4. Global Antidepressant Market Size and Forecast, Region (2024-2030) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Global Antidepressant Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2030) 4.1. North America Global Antidepressant Market Size and Forecast, by Product(2024-2030) 4.1.1. Tricyclic Antidepressants 4.1.2. Selective Serotonin Reuptake Inhibitors Herbicides 4.1.3. Serotonin-Norepinephrine Reuptake Inhibitors 4.1.4. Monoamine Oxidase Inhibitors 4.1.5. Serotonin Antagonist 4.1.6. Reuptake Inhibitors 4.2. North America Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 4.2.1. Major Depressive Disorder 4.2.2. Anxiety Disorders 4.2.3. Attention Deficit Hyperactivity Disorder 4.3. Global Antidepressant Market Size and Forecast, by End- User (2024-2030) 4.3.1. Hospitals & Clinics 4.3.2. Speciality Centres 4.3.3. Homecare 4.4. North America Global Antidepressant Market Size and Forecast, by Country (2024-2030) 4.4.1. United States 4.4.1.1. United States Global Antidepressant Market Size and Forecast, by Product(2024-2030) 4.4.1.1.1. Tricyclic Antidepressants 4.4.1.1.2. Selective Serotonin Reuptake Inhibitors Herbicides 4.4.1.1.3. Serotonin-Norepinephrine Reuptake Inhibitors 4.4.1.1.4. Monoamine Oxidase Inhibitors 4.4.1.1.5. Serotonin Antagonist 4.4.1.1.6. Reuptake Inhibitors 4.4.1.2. United States Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 4.4.1.2.1. Major Depressive Disorder 4.4.1.2.2. Anxiety Disorders 4.4.1.2.3. Attention Deficit Hyperactivity Disorder 4.4.1.3. United States Global Antidepressant Market Size and Forecast, by End- User (2024-2030) 4.4.1.3.1. Hospitals & Clinics 4.4.1.3.2. Speciality Centres 4.4.1.3.3. Homecare 4.4.1.4. Canada 4.4.1.5. Canada Global Antidepressant Market Size and Forecast, by Product(2024-2030) 4.4.1.5.1. Tricyclic Antidepressants 4.4.1.5.2. Selective Serotonin Reuptake Inhibitors Herbicides 4.4.1.5.3. Serotonin-Norepinephrine Reuptake Inhibitors 4.4.1.5.4. Monoamine Oxidase Inhibitors 4.4.1.5.5. Serotonin Antagonist 4.4.1.5.6. Reuptake Inhibitors 4.4.1.6. Canada Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 4.4.1.6.1. Major Depressive Disorder 4.4.1.6.2. Anxiety Disorders 4.4.1.6.3. Attention Deficit Hyperactivity Disorder 4.4.1.7. Canada Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 4.4.1.7.1. Hospitals & Clinics 4.4.1.7.2. Speciality Centres 4.4.1.7.3. Homecare 4.4.2. Mexico 4.4.2.1. Mexico Global Antidepressant Market Size and Forecast, by Product(2024-2030) 4.4.2.1.1. Tricyclic Antidepressants 4.4.2.1.2. Selective Serotonin Reuptake Inhibitors Herbicides 4.4.2.1.3. Serotonin-Norepinephrine Reuptake Inhibitors 4.4.2.1.4. Monoamine Oxidase Inhibitors 4.4.2.1.5. Serotonin Antagonist 4.4.2.1.6. Reuptake Inhibitors 4.4.2.2. Mexico Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 4.4.2.2.1. Major Depressive Disorder 4.4.2.2.2. Anxiety Disorders 4.4.2.2.3. Attention Deficit Hyperactivity Disorder 4.4.2.3. Online Mexico Global Antidepressant Market Size and Forecast, by End- User (2024-2030) 4.4.2.3.1. Hospitals & Clinics 4.4.2.3.2. Speciality Centres 4.4.2.3.3. Homecare 5. Europe Global Antidepressant Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2030) 5.1. Europe Global Antidepressant Market Size and Forecast, by Product(2024-2030) 5.2. Europe Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.3. Europe Global Antidepressant Market Size and Forecast, by End-Users (2024-2030) 5.4. Europe Global Antidepressant Market Size and Forecast, by Country (2024-2030) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Global Antidepressant Market Size and Forecast, by Product(2024-2030) 5.4.1.2. United Kingdom Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.4.1.3. United Kingdom Global Antidepressant Market Size and Forecast, by End-Users (2024-2030) 5.4.2. France 5.4.2.1. France Global Antidepressant Market Size and Forecast, by Product(2024-2030) 5.4.2.2. France Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.4.2.3. France Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 5.4.3. Germany 5.4.3.1. Germany Global Antidepressant Market Size and Forecast, by Product(2024-2030) 5.4.3.2. Germany Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.4.3.3. Germany Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.4.4. Italy 5.4.4.1. Italy Global Antidepressant Market Size and Forecast, by Product(2024-2030) 5.4.4.2. Italy Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.4.4.3. Italy Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 5.4.5. Spain 5.4.5.1. Spain Global Antidepressant Market Size and Forecast, by Product(2024-2030) 5.4.5.2. Spain Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.4.5.3. Spain Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 5.4.6. Sweden 5.4.6.1. Sweden Global Antidepressant Market Size and Forecast, by Product(2024-2030) 5.4.6.2. Sweden Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.4.6.3. Sweden Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 5.4.7. Austria 5.4.7.1. Austria Global Antidepressant Market Size and Forecast, by Product(2024-2030) 5.4.7.2. Austria Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.4.7.3. Austria Global Antidepressant Market Size and Forecast, by End-Users (2024-2030) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Global Antidepressant Market Size and Forecast, by Product(2024-2030) 5.4.8.2. Rest of Europe Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 5.4.8.3. Rest of Europe Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6. Asia Pacific Global Antidepressant Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2030) 6.1. Asia Pacific Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.2. Asia Pacific Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.3. Asia Pacific Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6.4. Asia Pacific Global Antidepressant Market Size and Forecast, by Country (2024-2030) 6.5. China 6.5.1.1. China Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.1.2. China Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.1.3. China Global Antidepressant Market Size and Forecast, by End-Users (2024-2030) 6.5.2. S Korea 6.5.2.1. S Korea Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.2.2. S Korea Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.2.3. S Korea Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6.5.3. Japan 6.5.3.1. Japan Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.3.2. Japan Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.3.3. Japan Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6.5.4. India 6.5.4.1. India Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.4.2. India Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.4.3. India Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6.5.5. Australia 6.5.5.1. Australia Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.5.2. Australia Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.5.3. Australia Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6.5.6. Indonesia 6.5.6.1. Indonesia Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.6.2. Indonesia Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.6.3. Indonesia Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6.5.7. Malaysia 6.5.7.1. Malaysia Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.7.2. Malaysia Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.7.3. Malaysia Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6.5.8. Vietnam 6.5.8.1. Vietnam Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.8.2. Vietnam Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.8.3. Vietnam Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6.5.9. Taiwan 6.5.9.1. Taiwan Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.9.2. Taiwan Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.9.3. Taiwan Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Global Antidepressant Market Size and Forecast, by Product(2024-2030) 6.5.10.2. Rest of Asia Pacific Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 6.5.10.3. Rest of Asia Pacific Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 7. Middle East and Africa Global Antidepressant Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2030) 7.1. Middle East and Africa Global Antidepressant Market Size and Forecast, by Product(2024-2030) 7.2. Middle East and Africa Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 7.3. Middle East and Africa Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 7.4. Middle East and Africa Global Antidepressant Market Size and Forecast, by Country (2024-2030) 7.4.1. South Africa 7.4.1.1. South Africa Global Antidepressant Market Size and Forecast, by Product(2024-2030) 7.4.1.2. South Africa Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 7.4.1.3. South Africa Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 7.4.2. GCC 7.4.2.1. GCC Global Antidepressant Market Size and Forecast, by Product(2024-2030) 7.4.2.2. GCC Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 7.4.2.3. GCC Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 7.4.3. Nigeria 7.4.3.1. Nigeria Global Antidepressant Market Size and Forecast, by Product(2024-2030) 7.4.3.2. Nigeria Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 7.4.3.3. Nigeria Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Global Antidepressant Market Size and Forecast, by Product(2024-2030) 7.4.4.2. Rest of ME&A Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 7.4.4.3. Rest of ME&A Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 8. South America Global Antidepressant Market Size and Forecast by Segmentation (by Value in USD Billion) (2024-2030 8.1. South America Global Antidepressant Market Size and Forecast, by Product(2024-2030) 8.2. South America Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 8.3. South America Global Antidepressant Market Size and Forecast, by Country (2024-2030) 8.4. South America Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 8.4.1. Brazil 8.4.1.1. Brazil Global Antidepressant Market Size and Forecast, by Product(2024-2030) 8.4.1.2. Brazil Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 8.4.1.3. Brazil Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 8.4.2. Argentina 8.4.2.1. Argentina Global Antidepressant Market Size and Forecast, by Product(2024-2030) 8.4.2.2. Argentina Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 8.4.2.3. Argentina Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Global Antidepressant Market Size and Forecast, by Product(2024-2030) 8.4.3.2. Rest Of South America Global Antidepressant Market Size and Forecast, by Depression Disorder (2024-2030) 8.4.3.3. Rest Of South America Global Antidepressant Market Size and Forecast, by End Users (2024-2030) 9. Global Antidepressant Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Product Segment 9.3.3. End-user Segment 9.3.4. Revenue (2023) 9.3.5. Company Locations 9.4. Market Analysis by Organized Players vs. Unorganized Players 9.4.1. Organized Players 9.4.2. Unorganized Players 9.5. Leading Global Antidepressant Market Companies, by market capitalization 9.6. Market Structure 9.6.1. Market Leaders 9.6.2. Market Followers 9.6.3. Emerging Players 9.7. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Merck & Co., Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. AstraZeneca plc 10.3. Eli Lilly and Company 10.4. Forest Laboratories 10.5. GlaxoSmithKline plc 10.6. H. Lundbeck A/S 10.7. Johnson & Johnson 10.8. Pfizer, Inc. 10.9. Sanofi S.A. 10.10. Allergan PLC 10.11. Sun Pharmaceuticals Pvt Ltd. 10.12. Alkermes Plc 10.13. Bristol Myers Squibb Co 10.14. Teva Pharmaceutical Industries Ltd. 10.15. Takeda Pharmaceutical Co. Ltd. 10.16. Novartis AG 10.17. Opko Health 11. Industry Recommendations 12. Global Antidepressant Market: Research Methodology
